Brown Advisory Inc Novavax Inc Transaction History

Brown Advisory Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$36.28 - $75.29 $725 - $1,505	20 Added 0.06%	31,548 $4.4 Million
Q1 2022 May 09, 2022	SELL	$69.73 - $142.9 $20,500 - $42,012	-294 Reduced 0.92%	31,528 $4.43 Million
Q4 2021 Jan 27, 2022	SELL	$134.56 - $217.97 $134,560 - $217,970	-1,000 Reduced 3.05%	31,822 $4.55 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $10,668 - $16,234	60 Added 0.18%	32,822 $6.8 Million
Q2 2021 Jul 29, 2021	SELL	$121.0 - $257.67 $35,453 - $75,497	-293 Reduced 0.89%	32,762 $6.96 Million
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $3.34 Million - $9.47 Million	29,585 Added 852.59%	33,055 $5.99 Million
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $2.94 Million - $6.6 Million	-37,000 Reduced 91.43%	3,470 $376,000
Q2 2020 Aug 14, 2020	SELL	$13.86 - $83.61 $91,822 - $553,916	-6,625 Reduced 14.07%	40,470 $3.37 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $52,249 - $212,720	13,295 Added 39.33%	47,095 $639,000
Q4 2019 Feb 14, 2020	SELL	$3.69 - $5.22 $7,380 - $10,440	-2,000 Reduced 5.59%	33,800 $134,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $42,812 - $83,496	10,650 Added 42.35%	35,800 $179,000
Q2 2019 Aug 12, 2019	BUY	$4.93 - $12.2 $123,989 - $306,830	25,150 New	25,150 $147,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.